PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation (PRCT) Stock Overview
Explore PROCEPT BioRobotics Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
-14.65
EPS (TTM)
$-1.72
ROE
-0.25%
PRCT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of PROCEPT BioRobotics Corporation (PRCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.65 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.